Carregant...
Cryptococcal therapies and drug targets: the old, the new and the promising
Half a century after the introduction of Amphotericin B the management of cryptococcosis remains unsatisfactory. The disease, caused primarily by the two fungal species Cryptococcus neoformans and Cryptococcus gattii, remains responsible for considerable morbidity and mortality despite standard medi...
Guardat en:
| Publicat a: | Cell Microbiol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5536168/ https://ncbi.nlm.nih.gov/pubmed/26990050 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cmi.12590 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|